LLLI: Lamperd Less Lethal Gains New Police Services Clients

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
277
LLLI: Lamperd Less Lethal Gains New Police Services Clients and Signs New Distributor for Wildlife Control; Initial Orders Received From All

Pepper Blast Program for Active Shooters Advances On-Track


SARNIA, ONTARIO, May 07, 2018 (GLOBE NEWSWIRE) -- Lamperd Less Lethal, Inc. (OTC PINK: LLLI), an innovation leader and manufacturer of advanced security solutions for law enforcement, military and other users worldwide, has begun working with four new police services clients in Canada since January of this year to supply products and services on an ongoing basis. The new clients have already started placing orders for our ammunition and distraction devices which they consider to be of the highest quality in terms of versatility, reliability, manufacturing methods and cost effectiveness. Lamperd Less Lethal is committed to supporting police services and all its clients in every way possible. Because of non-disclosure requirements, details on the exact types and quantities of products for the new police services clients cannot be released.

Additionally, in March of this year a new distributor agreement was signed with Kodiak Wildlife Products, Inc. of Canmore, Alberta, Canada for sales of the full Lamperd product line. The first order from Kodiak, for Lamperd distraction rounds to be sold to the general public, has already been booked and shipped. Last week Kodiak reported that customers were giving extremely positive feedback on the Lamperd 12 gauge distraction rounds for use as a humane method of bear control and had actually sold out the first shipment Lamperd made to them. Lamperd is now working to fill two new purchase orders from Kodiak for this product which are planned for delivery within the month of May. Kodiak also supplies products to various police services and Lamperd expects additional purchase orders from them in this capacity as well.

On Lamperd’s Pepper Blast program to address the threat of active shooters in schools and other public places, our VP of Training, Dr. Ed Bogats, Jr., has successfully completed his April training course and is currently preparing for his May schedule. Dr. Bogats, has now certified 15 new instructors from 9 different police agencies in the use of Lamperd products as counter-measures to active shooters. These instructors will introduce the products along with training to their respective school districts, when approved, so that teachers and school staff can use them to disable a shooter without the risks of employing guns or other deadly force measures. Lamperd is currently preparing for production and distribution of Pepper Blast to schools and other facilities throughout the U.S. and other countries.

For more information on Lamperd's products including photos, detailed product specifications and demonstration videos please visit the company website at http://www.lamperdlesslethal.com.

About the Company

Lamperd Less Lethal, Inc. (LLLI) is a developer, manufacturer and international sales company for advanced less lethal weapons, ammunition and other security products marketed to police, correctional, military and private security forces. The company sells over 300 different products including small & large caliber projectile guns, flash grenades, pepper spray grenades, 37mm & 40mm launching systems and interlocking riot shields. Lamperd also offers advisory services and hands-on training classes run by highly accredited instructors.

This press release contains forward-looking statements relating to Lamperd Less Lethal, Inc. Lamperd Less Lethal, Inc. undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.

Safe Harbor for Forward-Looking Statements:

This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.


Company Website: www.lamperdlesslethal.com

Lamperd Less Lethal on Facebook: https://www.facebook.com/lamperdlesslethal

Lamperd Less Lethal on Instagram: Https://www.instagram.com/llli_lamperd_lesslethal

Lamperd Less Lethal on Twitter: Https://www.twitter.com/llli_lesslethal

Barry Lamperd on Twitter: Https://www.twitter.com/lamperd_llli

Contact:
Lamperd Less Lethal, Inc.
Barry Lamperd, President & CEO
(519) 344-4445

SOURCE:
http://www.globenewswire.com/news-release/201...m-All.html

Lamperd Less Lethal (LLLI) Stock Research Links

LLLI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changshan's Tourism Boom: 22.8% Increase Over Holiday

Updated Category News Views 88

Changshan Grabs Attention This National Day You know, I blinked twice when I saw Changshan's tourist numbers this year. During the 2026 National Day holiday, they managed to snag 503,000 visitors. That's up by a whopping 22.8% from last year. If that doesn't grab your attention, I don't know what will. We're talking record numbers here, folks, and that's the kind of...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 51

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
VeriSilicon's GCNanoOptimaV Transforms Wearable Tech

Updated Category News Views 105

Revving Up Wearables with Next-Gen Graphics Well, folks, VeriSilicon's at it again, rolling out some cutting-edge technology in the form of their spanking new GCNanoOptimaV GPU IP. If you're scratching your head wondering what this means for your wrist-bound gadgets, hang tight—I'm about to spell it out. Architectural Innovations: Striking the Balance Here's the scoop...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 35

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Taiwantrade Introduces AI Sourcing Assistant: ASTRA

Updated Category News Views 121

Revolutionizing AI-Powered Global Sourcing Here's the scoop from Taipei: Taiwantrade's just dropped ASTRA, their brand-spanking-new AI sourcing assistant, and it's got the industry buzzing. When it comes to cutting through the clutter and finding the right supplier, this could change the game for how international buyers scrape deals out of Taiwan. Simplifying Complex...

Continue Reading
APEC CEO Summit Marries Innovation and Global Ties

Updated Category News Views 21

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Seniors and Cybersecurity: Tackling Holiday Threats

Updated Category News Views 90

Battle Against the Holiday Cyber Threats This ain't just about slipping on an ugly sweater this holiday season. The ugly truth is as the colder weather rolls around, so do the cyber vultures—praying on the unsuspecting, especially our seniors. Fraudsters are cranking up the heat, exploiting online shopping sprees, hefty travel plans, and even the warm embrace of a...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
New Player in Options Trading: Mercury Alerts Launches

Updated Category News Views 28

Enter Mercury Alerts in a Changing Trading Landscape Damn, if there ain't some days that throw us a curveball, today's one of them. Since Cboe pulled the plug on the beloved Trade Alert, it's like chopping off a trader's lifeline without a backup. Just when everyone was getting cozy with the way Trade Alert fed the options flow into our screens, here comes Harmeet Goindi...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Upcoming Class Action Against Walgreens for WBA Shareholders

Updated Category News Views 146

Join the Upcoming Class Action Against Walgreens for WBA Shareholders The Gross Law Firm has issued an important notice for shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) regarding a potential class action lawsuit. If you purchased shares of WBA within the specified dates, you may want to consider your options for participation. Class Action Overview This...

Continue Reading
US Employment Surge Sparks Optimism in Asian Markets

Updated Category News Views 187

US Employment Surge Sparks Optimism in Asian Markets By Jamie McGeever As Asian markets prepare to open, the global economic landscape is shifting dramatically, spurred by astonishing U.S. employment figures. This unexpected data has shifted market perceptions and prompted investors to reconsider their strategies. Strong September Non-Farm Payrolls Report The report on...

Continue Reading
Block, Inc. Investors Urged to Connect with Legal Support Now

Updated Category News Views 161

Understanding Your Rights as a Block, Inc. Investor For investors of Block, Inc. looking to recover their losses, it's crucial to understand the legal avenues available to them. The recent issues surrounding Block should encourage affected investors to seek assistance promptly. How to Recover Losses The Portnoy Law Firm is available to help investors navigate the...

Continue Reading
Key Takeaways from Implantica AG's Annual General Meeting

Updated Category News Views 204

Highlights from Implantica AG's Annual General Meeting On a recent date, the annual general meeting (AGM) of Implantica AG (publ) took place in Ruggell. This important gathering allowed shareholders to review key proposals and resolutions put forth by the board of directors, all of which were adopted. Below is a detailed overview of the notable decisions made during this...

Continue Reading
BRIUMVI's 5-Year Trials Show Significant Efficacy and Safety

Updated Category News Views 116

Key Findings from BRIUMVI's 5-Year Trials TG Therapeutics, Inc. (NASDAQ:TGTX) has revealed impressive results from its long-term Phase 3 trials, ULTIMATE I & II, which focus on BRIUMVI (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis (RMS). These findings were presented at the respected European Committee for Treatment and Research in Multiple...

Continue Reading